HomeSANA • NASDAQ
Sana Biotechnology Inc
add
$3.19
9.25%
After Hours:(0.00%)0.00
$3.19
Closed: Jul 3, 4:53:31 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 48.77M | -53.71% |
Net income | -49.39M | 54.05% |
Net profit margin | — | — |
Earnings per share | -0.20 | 37.50% |
EBITDA | -45.12M | 55.59% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 104.70M | -66.34% |
Total assets | 445.47M | -34.62% |
Total liabilities | 236.39M | -22.81% |
Total equity | 209.08M | — |
Shares outstanding | 225.56M | — |
Price to book | 3.14 | — |
Return on assets | -25.76% | — |
Return on capital | -37.35% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -49.39M | 54.05% |
Cash from operations | -48.66M | 25.86% |
Cash from investing | 16.60M | 121.50% |
Cash from financing | 982.00K | -99.47% |
Net change in cash | -31.07M | -171.37% |
Free cash flow | -32.11M | 60.97% |
Previous close
$2.92
Day range
$2.94 - $3.24
Year range
$1.26 - $7.40
Market cap
719.52M USD
Avg Volume
4.99M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
2018
Headquarters
Website
Employees
194
